Trial Profile
Phase II Trial of Carboplatin plus S-1 for Previously Untreated Patients with Advanced Non-small-cell Lung Cancer complicated by Interstitial Pneumonia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2019
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 08 Jul 2013 New trial record